About
Team
DepoVax
™
Platform & Pipeline
Investors
Partners
News & Events
Careers
Contact
Press Releases
In the News
Upcoming Events
Share
In The News
2012 In The News
2013
2012
2011
2010
2009
Preliminary drug tests show positive results
Colleen Cosgrove, Business Reporter • The Chronicle Herald
Date: Oct 25, 2012
Vaccine trial gets good results
Brett Bundale • The Chronicle Herald
Date: Oct 09, 2012
Winning Immunity
Janet Damianopoulos • Biotechnology Focus
Date: Aug 23, 2012
Immunovaccine loss attributed to R&D costs
Brett Bundale • The Chronicle Herald
Date: Aug 17, 2012
Immunovaccine's CEO John Trizzino featured on PharmaTV
Date: Jul 18, 2012
Halifax biotechnology firm working on next generation of pet vaccines
Brett Bundale, Business Reporter • The Chronicle Herald
Date: May 11, 2012
Passive vaccine could treat cocaine overdose
Suzanne Elvidge • FierceVaccines
Date: Apr 19, 2012
Halifax biotech firms get results in U.S.
John Demont • The Chronicle Herald
Date: Apr 05, 2012
Could a vaccine crack cocaine abuse?
By Suzanne Elvidge • FierceVaccines
Date: Mar 15, 2012
Nova Scotia's Immunovaccine partners with U.S. college in addiction research
By Brett Bundale • The Chronicle Herald
Date: Mar 14, 2012
Immunovaccine, Weill Cornell Medical College to Progress Anti-cocaine Vaccine
GEN- Genetic Engineering & Biotechnology News
Date: Mar 12, 2012
Biotech company raises $2.8 million for R&D
John Demont, Business Reporter • The Chronicle Herald
Date: Mar 08, 2012
How to Succeed in DevelopingCancer Vaccine is No Easy Job - Canada Immunovaccine Inc.
Tomoko Masuda • Nikkei Biotech
Date: Mar 06, 2012
Other News to Note
BioWorld Today
Date: Feb 16, 2012
Immunovaccine is developing NIH-funded biodefense vaccines
By Suzanne Elvidge • FierceVaccines
Date: Feb 16, 2012
Immunovaccine's delivery platform to be tested in fight against bioterrorism
Bill Power • The Chronicle Herald
Date: Feb 15, 2012
Biotech firm to issue shares
By John Demont • The Chronicle Herald
Date: Feb 10, 2012
Orphan Drugs, Growth and Controlling Risk Headline J. P. Morgan
Gail Dutton • Genetic Engineering & Biotechnology News
Date: Jan 16, 2012
The Number Two Killer Globally, Infectious Disease is a Great Place to Invest
Partnering News
Date: Jan 13, 2012
Immunovaccine, Inc: Developing More Effective Cancer Vaccines
by Dr. Marc Mansour • Drug Development & Delivery
Date: Jan 12, 2012
Clinic Roundup
BioWorld
Date: Jan 05, 2012
Anti-cancer Drug Trials Start
Joann Alberstat • The Chronicle Herald
Date: Jan 04, 2012